Plum Alley

Plum Alley is a New York-based venture capital firm established in 2015, known for its distinctive investment thesis centered on supporting early-stage technology and healthcare companies. A core tenet of their strategy is investing in startups with at least one woman founder, addressing a significant funding gap in the venture ecosystem. They target Seed and Series A rounds, often taking a lead or co-lead position, demonstrating a hands-on approach to portfolio company development.

The firm's investment scope is primarily focused on deep technology and healthcare sectors, seeking out innovative solutions that leverage cutting-edge advancements. This includes areas such as AI, biotech, advanced materials, and digital health. Plum Alley's commitment extends beyond capital, aiming to provide strategic guidance and leverage their network to help founders scale their businesses effectively. Their emphasis on companies with women founders is not merely a social mission but a strategic one, recognizing the often-overlooked potential and strong returns generated by diverse founding teams.

Plum Alley has progressively grown its capital base, successfully raising three dedicated venture funds. Their latest vehicle, Plum Alley Ventures III, closed with $40 million, bringing their total assets under management across all funds to approximately $90 million. This increased capital allows them to write more substantial initial checks and provide robust follow-on funding to their most promising portfolio companies. To date, the firm has made over 85 investments, building a diverse portfolio that reflects their commitment to impactful innovation and inclusive entrepreneurship. Their typical initial check sizes range from $1 million to $3 million, reflecting their capacity to support significant early-stage growth.